Eastwood Bio-Medical Canada Inc (V:EBM) — Market Cap & Net Worth
Market Cap & Net Worth: Eastwood Bio-Medical Canada Inc (EBM)
Eastwood Bio-Medical Canada Inc (V:EBM) has a market capitalization of $89.55 Million (CA$123.80 Million) as of September 17, 2026. Listed on the V stock exchange, this Canada-based company holds position #19687 globally and #664 in its home market, demonstrating a -5.26% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Eastwood Bio-Medical Canada Inc's stock price CA$1.80 by its total outstanding shares 68885969 (68.89 Million). Also see EBM total assets for a full breakdown of the balance sheet.
Eastwood Bio-Medical Canada Inc Market Cap History: 2015 to 2026
Eastwood Bio-Medical Canada Inc's market capitalization history from 2015 to 2026. Data shows growth from $17.44 Million to $89.70 Million (9.78% CAGR). Also see Eastwood Bio-Medical Canada Inc (EBM) cash conversion ratio for how efficiently the company converts equity into cash flow.
Eastwood Bio-Medical Canada Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Eastwood Bio-Medical Canada Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check Eastwood Bio-Medical Canada Inc stock price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
51.61x
Eastwood Bio-Medical Canada Inc's market cap is 51.61 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $6.23 Million | $463.93K | -$468.48K | 13.43x | N/A |
| 2017 | $3.74 Million | $479.73K | -$489.62K | 7.79x | N/A |
| 2018 | $274.07 Million | $743.97K | -$861.98K | 368.39x | N/A |
| 2019 | $124.08 Million | $1.29 Million | -$579.68K | 95.97x | N/A |
| 2020 | $99.66 Million | $718.34K | -$860.03K | 138.74x | N/A |
| 2021 | $69.76 Million | $981.05K | -$611.34K | 71.11x | N/A |
| 2022 | $49.83 Million | $1.30 Million | -$160.58K | 38.34x | N/A |
| 2023 | $27.41 Million | $867.94K | -$546.60K | 31.58x | N/A |
| 2024 | $26.91 Million | $702.08K | -$455.87K | 38.33x | N/A |
| 2025 | $40.36 Million | $782.08K | -$332.77K | 51.61x | N/A |
Competitor Companies of EBM by Market Capitalization
Companies near Eastwood Bio-Medical Canada Inc in the global market cap rankings as of September 17, 2026. Review tangible net worth ratio of Eastwood Bio-Medical Canada Inc to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Eastwood Bio-Medical Canada Inc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #186 globally with a market cap of $130.44 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #353 globally with a market cap of $78.29 Billion USD.
- CSL Ltd (AU:CSL): Ranked #457 globally with a market cap of $59.82 Billion USD ( AU$84.54 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #506 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #186 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.44 Billion | $514.63 |
| #353 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $78.29 Billion | $774.11 |
| #457 | CSL Ltd | AU:CSL | $59.82 Billion | AU$174.26 |
| #506 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $143.77 |
Eastwood Bio-Medical Canada Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, Eastwood Bio-Medical Canada Inc's market cap moved from $17.44 Million to $ 89.70 Million, with a yearly change of 9.78%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CA$89.70 Million | +122.22% |
| 2025 | CA$40.36 Million | +50.00% |
| 2024 | CA$26.91 Million | -1.82% |
| 2023 | CA$27.41 Million | -45.00% |
| 2022 | CA$49.83 Million | -28.57% |
| 2021 | CA$69.76 Million | -30.00% |
| 2020 | CA$99.66 Million | -19.68% |
| 2019 | CA$124.08 Million | -54.73% |
| 2018 | CA$274.07 Million | +7233.33% |
| 2017 | CA$3.74 Million | -40.00% |
| 2016 | CA$6.23 Million | -64.29% |
| 2015 | CA$17.44 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 16th, 2026 the market cap of Eastwood Bio-Medical Canada Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $89.55 Million USD |
| MoneyControl | $89.55 Million USD |
| MarketWatch | $89.55 Million USD |
| marketcap.company | $89.55 Million USD |
| Reuters | $89.55 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Eastwood Bio-Medical Canada Inc
Eastwood Bio-Medical Canada Inc. markets, develops research, and distributes natural health products under the Eleotin brand in Canada, the United States, and Asia. The company distributes Eleotin, which provides natural remedies for metabolic disorders, such as blood glucose disorders, hypertension, and obesity. It also offers Eleotin A 700 for the treatment for spleen deficiency, lack of appeti… Read more